Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04877015 · ClinicalTrials.gov registry record · NA
Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease
A NA study, sponsored by Synergic Medical Technologies.
- Terminated
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT04877015: Clinical Trial NA study, sponsored by Synergic Medical Technologies.
NCT04877015 is a NA study that was terminated before completion, run by Synergic Medical Technologies. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04877015, a NA study, was terminated before completion, sponsored by Synergic Medical Technologies.
- TERMINATED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on motor ability within Parkinson's patients. vCR will be administered with a device called the VT Brain Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as levodopa and or deep brain stimulation. This study will include a dedicated sham that will aid in understanding true treatment effects from vCR.
Primary Outcome
This scale measures motor ability within Parkinson's patients. For part 3, the scales minimum values is 0 and max value is 132. Higher scores indicate more impaired motor ability, while lower scores indicate less impaired motor ability. A score of 0 indicates no motor impairment. This evaluation will be done in person at baseline, 3,6 and 7 months. The remote version will be done at 10, 13 and 14 months
Interventions
- DEVICE Active Vibrotactile Coordinated Reset (vCR)
- DEVICE Sham Vibrotactile Coordinated Reset (vCR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2021-12-07 |
| Est. Completion | 2022-10-14 |
| Phase | NA |
Why NCT04877015 stopped before completion
NCT04877015 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Active Vibrotactile Coordinated Reset (vCR) is the first listed.
NCT04877015 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04877015 about?
NCT04877015 is a clinical study titled "Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease". The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on motor ability within Parkinson's patients. vCR will be administered with a device called the VT Brain Glove. vCR is expected to provide patients with a non-invasive alternative to the most wid...
What is the current status of trial NCT04877015?
This trial is currently terminated. It is a NA study. The enrollment target is 36 participants. The study started on 2021-12-07. Estimated completion is 2022-10-14.
What interventions are being tested in trial NCT04877015?
The interventions under investigation include: Active Vibrotactile Coordinated Reset (vCR) (DEVICE), Sham Vibrotactile Coordinated Reset (vCR) (DEVICE).
Who is sponsoring clinical trial NCT04877015?
This trial is sponsored by Synergic Medical Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04877015's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI